Introducing Novel Guidelines for Patient Engagement in Research

Published Mar 20, 2017

Using Real-World Examples to Inform the Integration of Patients as Full Research Partners in Outcomes Research

  Princeton, NJ—March 20, 2017—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) announced today the publication of suggested guidelines on establishing research partnerships with patients. The report of these novel recommendations for outcomes researchers entitled, Emerging Guidelines for Patient Engagement in Research, was published in the March 2017 issue of Value in Health.   “Involving patients in the development of new patient-reported outcome measures helps ensure that the outcomes that matter most to people living with health conditions are captured,” said corresponding author Susan Bartlett, PhD, McGill University, Montreal, Quebec, Canada.“ And while there are many methods of consulting with patients,” she added, “consensus on good practice and guidance for establishing collaborative research partnerships is limited. In this report, we describe and discuss different experiences of integrating patients as full research partners in outcomes research from multiple perspectives (e.g., researcher, patient, funder), drawing from three real-world examples.” The authors offer 6 specific principles to guide the integration of patients as full partners in outcomes research: 1) establishing supportive organizational/institutional policies; 2) cultivating supportive attitudes of researchers and patient research partners; 3) adhering to principles of respect, trust, reciprocity, and co-learning; 4) addressing training needs of all team members to ensure communications and that patient research partners are familiar with and conversant in the language and process of research; 5) identifying the resources and advanced planning required for successful patient engagement; and 6) recognizing the value of partnerships across all stages of research. "It is already clear that involving patients as partners in the research process produces positive and lasting improvements," said lead co-author John R. Kirwan, MD, Emeritus Professor at the University of Bristol, Bristol, United Kingdom. The authors highlight that more research is needed to identify the skills and qualities that contribute to successful research partnerships in terms of individual and collective needs, values, and required resources. They also note that further work is needed to develop insights and best practices for training researchers and patients to work well together in designing new measures and implementing outcomes research.

###

  ABOUT ISPOR The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is a nonprofit, international, educational and scientific organization that promotes health economics and outcomes research excellence to improve decision making for health globally. Web: www.ispor.org | LinkedIn: http://bit.ly/ISPOR-LIn | Twitter: http://bit.ly/ISPOR-T (@ISPORorg) | YouTube: http://bit.ly/ISPOR-YT | Facebook: http://bit.ly/ISPOR-FB   ABOUT VALUE IN HEALTH Value in Health (ISSN 1098-3015) is an international, indexed journal that publishes original research and health policy articles that advance the field of health economics and outcomes research to help health care leaders make evidence-based decisions. The journal’s 2015 impact factor score is 3.824. Value in Health is ranked 3rd out of 74 journals in health policy and services (social sciences), 8th out of 87 journals in health care sciences and services, and 10th out of 344 journals in economics (social sciences). Value in Health publishes 10 issues a year and circulates to more than 10,000 readers around the world. Web: www.ispor.org/valueinhealth | Twitter: http://bit.ly/ISPORjournals-T (@ISPORjournals)    

Related Stories

ISPOR Task Force Addresses Critical Gap in Surrogate Endpoint Guidance

May 28, 2026

Value in Health, announced the publication of an ISPOR Good Practices Report providing guidance on the use of surrogate endpoint evaluation methods in health technology assessment (HTA) decision making. The report, “Methods for Evaluation of Surrogate Endpoints for HTA Decision Making: A Good Practices Report of an ISPOR Task Force,” was published in the May 2026 issue of Value in Health.

How Is Health Valued in the United Kingdom? We Finally Have a Better Answer

May 27, 2026

Value in Health, the official journal of ISPOR—The Professional Society for Health Economics and Outcomes Research, announced today the publication of a pair of companion articles that together establish both the methodological foundation of the first definitive UK value set for the EQ-5D-5L and the practical implications of adopting it—thus equipping health technology assessment decision makers with a UK value set suitable for informing policy. The articles were featured in the May 2026 issue of Value in Health.

From Promise to Proof: Strengthening the Evidence Base for Digital Health Technologies

Apr 28, 2026

Value in Health announced the publication of a special themed section of research papers that advances evidence and methods for evaluating the real-world value of digital health technologies.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×